Usually that would be considered a good thing.
How do they justify such a pie-in-the-sky yearly price estimate in the fifties. I think somewhere in the twenties is far more likely.
someone who wouldn't drop it. MM just doesn't have the grip. Now they have let their core products and services deteriorate. Look for the low twenties by Thanksgiving.
with negligible or minor tax liability cannot still be achieved. That would make this a great buying opportunity were MM not in charge.
It looks like a lot of folks see a buying opportunity in spite of MM.
They have placed all of their eggs in the Alibaba basket and have let their core products and services deteriorate. This trend will continue until they fire Myer.
...While there is no guarantee that any experimental-stage drug will gain regulatory approval, I find Agenus a compelling buy right now because it has multiple checkpoint inhibitors heading into clinical trials with partners Merck and Incyte. As an added bonus, the company sports the Retrocyte Display platform and the rights to antibodies targeting Carcinoembryonic Antigen Cell Adhesion Molecule 1 that should lead to the discovery of several additional therapeutic targets.
All told, Agenus' broad-based clinical approach to immuno-oncology gives it multiple shots on goal toward potentially developing a blockbuster cancer therapy, and that's a big deal for a company with a market cap of around $390 million.
the value of Yahoo's core business is negative.
17.71 might not be a low enough average cost basis to make any money on this POS after the spin off.
Is this stock worth holding after the spin off?
On Management. With concerns around the core's health and some risk in the Alibaba spin, investors have begun to revisit management and the strategy. First, the executive turnover has accelerated in 2015 with key executives like Jackie Reses, Kathy Savitt, and Scott Burke having left. This year alone, we count 13 key executives who have left, which disrupts continuity. Additionally concerning is that Jackie Reses was supposed to run the Aabaco spin process and investors are unclear on who is leading that now. Further, the CEO recently stated on the earnings call that "the design and changes in Yahoo!'s leadership team are the result of careful planning to achieve the necessary skills, passion, and the ability to execute growth in our business. Our leadership team today is unequivocally the strongest during my tenure." This seems confusing to investors, as the departed executives were hand-picked by the CEO originally. The company also mentioned on the earnings call that now may be "a unique opportunity to reset" and Recode reports that the company is hiring a consulting firm to plan yet another reorganization. Investors are asking that if this is true, is this a natural time to consider changes at the CEO level as well, given the issues discussed above. We believe the board must assess if the current management team has support of 4 factions: senior executives, employees, partners, and investors. If not, we think a seamless transition to new leadership could be in the best interest of the company and shareholders.